NEUVIVO Trademark

Trademark Overview


On Thursday, September 9, 2021, a trademark application was filed for NEUVIVO with the United States Patent and Trademark Office. The USPTO has given the NEUVIVO trademark a serial number of 97020234. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, August 21, 2024. This trademark is owned by Neuvivo, Inc.. The NEUVIVO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

medicines and pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (als); medicines and pharmaceutical preparations for the treatment of neurodegenerative diseases; medicines and pharmaceutical preparations for the treatment of central nervous system and peripheral nervous system diseases and disorders; medicines and pharmaceutical preparations for the treatment of viral diseases

scientific research for medical purposes in the field of amyotrophic lateral sclerosis (als), neurodegenerative diseases, central nervous system and peripheral nervous system diseases and disorders, and viral diseases
neuvivo

General Information


Serial Number97020234
Word MarkNEUVIVO
Filing DateThursday, September 9, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements


Description of MarkThe mark consists of the word NEUVIVO in stylized lettering, with the letters NEU in bold, a bar through the center of the N and E, and VIVO in narrower lettering.
Goods and Servicesmedicines and pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (als); medicines and pharmaceutical preparations for the treatment of neurodegenerative diseases; medicines and pharmaceutical preparations for the treatment of central nervous system and peripheral nervous system diseases and disorders; medicines and pharmaceutical preparations for the treatment of viral diseases
Goods and Servicesscientific research for medical purposes in the field of amyotrophic lateral sclerosis (als), neurodegenerative diseases, central nervous system and peripheral nervous system diseases and disorders, and viral diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 19, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeuvivo, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94301

Party NameNeuvivo, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Altos, CA 94024

Trademark Events


Event DateEvent Description
Monday, June 13, 2022ASSIGNED TO EXAMINER
Monday, September 13, 2021NEW APPLICATION ENTERED
Tuesday, October 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 20, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, June 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 2, 2022ASSIGNED TO EXAMINER
Tuesday, March 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 8, 2023SOU EXTENSION 2 FILED
Friday, March 10, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 10, 2023SOU EXTENSION 1 FILED
Friday, March 10, 2023SOU EXTENSION 1 GRANTED
Friday, September 8, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 8, 2023SOU EXTENSION 2 GRANTED
Wednesday, March 13, 2024SOU EXTENSION 3 FILED
Tuesday, September 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2024SOU EXTENSION 3 GRANTED
Wednesday, August 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU EXTENSION 4 GRANTED
Wednesday, August 21, 2024SOU EXTENSION 4 FILED
Thursday, March 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2024SOU TEAS EXTENSION RECEIVED